» Articles » PMID: 34520545

Functional Correction of CFTR Mutations in Human Airway Epithelial Cells Using Adenine Base Editors

Overview
Specialty Biochemistry
Date 2021 Sep 14
PMID 34520545
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the CFTR gene that lead to premature stop codons or splicing defects cause cystic fibrosis (CF) and are not amenable to treatment by small-molecule modulators. Here, we investigate the use of adenine base editor (ABE) ribonucleoproteins (RNPs) that convert A•T to G•C base pairs as a therapeutic strategy for three CF-causing mutations. Using ABE RNPs, we corrected in human airway epithelial cells premature stop codon mutations (R553X and W1282X) and a splice-site mutation (3849 + 10 kb C > T). Following ABE delivery, DNA sequencing revealed correction of these pathogenic mutations at efficiencies that reached 38-82% with minimal bystander edits or indels. This range of editing was sufficient to attain functional correction of CFTR-dependent anion channel activity in primary epithelial cells from CF patients and in a CF patient-derived cell line. These results demonstrate the utility of base editor RNPs to repair CFTR mutations that are not currently treatable with approved therapeutics.

Citing Articles

Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing.

Carrozzo I, Maule G, Gentile C, Umbach A, Ciciani M, Guidone D Mol Ther. 2025; 33(3):970-985.

PMID: 39797401 PMC: 11897810. DOI: 10.1016/j.ymthe.2025.01.011.


Mechanism of Genome Editing Tools and Their Application on Genetic Inheritance Disorders.

Oh D Glob Med Genet. 2024; 11(4):319-329.

PMID: 39583120 PMC: 11405120. DOI: 10.1055/s-0044-1790558.


DNA-PKcs inhibition improves sequential gene insertion of the full-length cDNA in airway stem cells.

Stack J, Rayner R, Nouri R, Suarez C, Kim S, Kanke K Mol Ther Nucleic Acids. 2024; 35(4):102339.

PMID: 39398224 PMC: 11470261. DOI: 10.1016/j.omtn.2024.102339.


Amphiphilic shuttle peptide delivers base editor ribonucleoprotein to correct the CFTR R553X mutation in well-differentiated airway epithelial cells.

Kulhankova K, Cheng A, Traore S, Auger M, Pelletier M, Hervault M Nucleic Acids Res. 2024; 52(19):11911-11925.

PMID: 39315713 PMC: 11514481. DOI: 10.1093/nar/gkae819.


Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungs.

Kavanagh E, Tzeng S, Sharma N, Cutting G, Green J Biomaterials. 2024; 313:122753.

PMID: 39217793 PMC: 11571037. DOI: 10.1016/j.biomaterials.2024.122753.


References
1.
Valley H, Bukis K, Bell A, Cheng Y, Wong E, Jordan N . Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cells. J Cyst Fibros. 2018; 18(4):476-483. DOI: 10.1016/j.jcf.2018.12.001. View

2.
Highsmith W, Burch L, Zhou Z, Olsen J, Boat T, Spock A . A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med. 1994; 331(15):974-80. DOI: 10.1056/NEJM199410133311503. View

3.
Miller S, Wang T, Randolph P, Arbab M, Shen M, Huang T . Continuous evolution of SpCas9 variants compatible with non-G PAMs. Nat Biotechnol. 2020; 38(4):471-481. PMC: 7145744. DOI: 10.1038/s41587-020-0412-8. View

4.
George L, Sullivan S, Giermasz A, Rasko J, Samelson-Jones B, Ducore J . Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. N Engl J Med. 2017; 377(23):2215-2227. PMC: 6029626. DOI: 10.1056/NEJMoa1708538. View

5.
Mali P, Yang L, Esvelt K, Aach J, Guell M, DiCarlo J . RNA-guided human genome engineering via Cas9. Science. 2013; 339(6121):823-6. PMC: 3712628. DOI: 10.1126/science.1232033. View